X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (184) 184
humans (177) 177
male (126) 126
cardiac & cardiovascular systems (124) 124
female (116) 116
middle aged (71) 71
adult (68) 68
heart failure (51) 51
hypertrophic cardiomyopathy (47) 47
risk factors (41) 41
adolescent (40) 40
echocardiography (39) 39
cardiovascular (38) 38
prognosis (38) 38
aged (36) 36
child (36) 36
cardiomyopathy (34) 34
heart (31) 31
diagnosis (28) 28
abridged index medicus (27) 27
follow-up studies (27) 27
cardiology (24) 24
analysis (23) 23
children (21) 21
mutation (21) 21
cohort studies (19) 19
european-society (19) 19
child, preschool (18) 18
exercise test (18) 18
hypertension (18) 18
phenotype (18) 18
task-force (18) 18
treatment outcome (18) 18
care and treatment (17) 17
genetic aspects (17) 17
management (17) 17
prospective studies (17) 17
young adult (17) 17
disease (16) 16
severity of illness index (16) 16
cardiomyopathy, hypertrophic (15) 15
case-control studies (15) 15
dilated cardiomyopathy (15) 15
exercise (15) 15
genetics & heredity (15) 15
heart failure - diagnosis (15) 15
heart failure - physiopathology (15) 15
italy (15) 15
mortality (15) 15
multivariate analysis (15) 15
research (15) 15
retrospective studies (15) 15
health aspects (14) 14
heart-failure (14) 14
reproducibility of results (14) 14
athletes (13) 13
cardiomyopathy, hypertrophic - diagnosis (13) 13
genetics (13) 13
guidelines (13) 13
infant (13) 13
predictive value of tests (13) 13
cardiomyopathy, hypertrophic - complications (12) 12
echocardiography - methods (12) 12
hypertrophy, left ventricular - diagnostic imaging (12) 12
prevalence (12) 12
right ventricle (12) 12
risk assessment (12) 12
sudden cardiac death (12) 12
athlete's heart (11) 11
cardiac patients (11) 11
congenital heart disease (11) 11
death, sudden, cardiac - prevention & control (11) 11
diagnosis, differential (11) 11
echocardiography, doppler (11) 11
heart ventricles - diagnostic imaging (11) 11
internal medicine (11) 11
mutations (11) 11
oxygen consumption (11) 11
pedigree (11) 11
tissue doppler (11) 11
cardiac resynchronization therapy (10) 10
cardiomyopathy, hypertrophic - genetics (10) 10
cardiomyopathy, hypertrophic - mortality (10) 10
cardiomyopathy, hypertrophic - therapy (10) 10
cardiovascular disease (10) 10
heart transplantation (10) 10
hypertrophy (10) 10
peripheral vascular disease (10) 10
proportional hazards models (10) 10
recommendations (10) 10
risk (10) 10
stroke volume (10) 10
studies (10) 10
cardiomyopathies (9) 9
cardiopulmonary exercise test (9) 9
death, sudden, cardiac - etiology (9) 9
dysfunction (9) 9
electrocardiography (9) 9
heart attacks (9) 9
heart diseases (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The American Journal of Cardiology, ISSN 0002-9149, 08/2016, Volume 118, Issue 3, pp. 432 - 439
Journal Article
International journal of molecular sciences, ISSN 1661-6596, 12/2018, Volume 19, Issue 12, p. 3726
Anderson-Fabry disease (FD) is a rare, progressive, multisystem storage disorder caused by the partial or total deficit of the lysosomal enzyme... 
Fabry disease | GLA gene | LysoGb3 | DIAGNOSIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | LYSOSOMAL STORAGE DISORDERS | VARIANT | CHEMISTRY, MULTIDISCIPLINARY | Index Medicus
Journal Article
Orphanet Journal of Rare Diseases, ISSN 1750-1172, 2013, Volume 8, Issue 1, pp. 91 - 91
Background: We report an Italian family in which the proband showed a severe phenotype characterized by the association of congenital fiber type disproportion... 
Left ventricular noncompact cardiomyopathy | Whole exome sequencing | Integrin alpha 7 (ITGA7) | Myosin heavy chain 7B (MYH7B) | Congenital type fiber disproportion | MYOCARDIUM | MEDICINE, RESEARCH & EXPERIMENTAL | DILATED CARDIOMYOPATHY | FAMILY | FIBER-TYPE DISPROPORTION | ADHESION | DISEASE | GENETICS & HEREDITY | NON-COMPACTION | EXPRESSION | COMMON-CAUSE | Myosin Heavy Chains - chemistry | Humans | Middle Aged | Child, Preschool | Molecular Sequence Data | Myosin Heavy Chains - genetics | Male | Myotonia Congenita - physiopathology | Mutation, Missense | Antigens, CD - genetics | Cardiomyopathies - etiology | Exome | Young Adult | Cardiomyopathies - genetics | Cardiomyopathies - physiopathology | Female | Antigens, CD - chemistry | Myotonia Congenita - genetics | Child | Amino Acid Sequence | Integrin alpha Chains - chemistry | Cardiac Myosins - genetics | Sequence Analysis, DNA | Myotonia Congenita - etiology | Heart Ventricles - abnormalities | Phenotype | Pedigree | Adolescent | Italy | Cardiac Myosins - chemistry | Integrin alpha Chains - genetics | Gene mutations | Cardiomyopathy | Genetic aspects | Research | Health aspects | Heart diseases | Risk factors | Integrins | Medical research | Genetic research | Medicine, Experimental | Genetics | Mutation | Genes | Muscular dystrophy | Index Medicus | Basal lamina
Journal Article
Heart, ISSN 1355-6037, 03/2017, Volume 103, Issue 5, p. 390
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2007, Volume 100, Issue 4, pp. 736 - 741
Journal Article
Journal Article
European Heart Journal, ISSN 0195-668X, 08/2014, Volume 35, Issue 30, pp. 2010 - 2020
Journal Article
Journal Article
Endocrine, Metabolic and Immune Disorders - Drug Targets, ISSN 1871-5303, 12/2016, Volume 16, Issue 4, pp. 264 - 269
Background: Rhinocerebral mucormycosis is a rare, rapidly progressive and potentially lethal disease almost exclusively affecting immunocompromised hosts or... 
Zygomycetes | Mucorales | Surgical debridement | Rhinocerebral mucormycosis | Immunocompromised patients | Sinusitis | surgical debridement | MANAGEMENT | SAFETY | HOST | IMMUNOLOGY | ENDOCRINOLOGY & METABOLISM | immunocompromised patients | sinusitis | PHARMACOLOGY & PHARMACY | PATIENT | rhinocerebral mucormycosis
Journal Article
Journal Article
Journal Article
Heart, ISSN 1355-6037, 05/2017, Volume 103, Issue 9, pp. 672 - 678
ObjectivesAtrial fibrillation (AF) is associated with increased morbidity and mortality in patients with hypertrophic cardiomyopathy (HCM). The primary aim of... 
ARRHYTHMIAS | IMPACT | CARDIAC & CARDIOVASCULAR SYSTEMS | EVENTS | MANAGEMENT | MYOCARDIAL FIBROSIS | GUIDELINES | RISK | DEATH | CLINICAL-COURSE | EUROPEAN-SOCIETY | Multivariate Analysis | Prevalence | Humans | Middle Aged | Male | Atrial Fibrillation - physiopathology | Cardiomyopathy, Hypertrophic - drug therapy | Incidence | Protective Factors | Action Potentials | Heart Rate - drug effects | Atrial Fibrillation - mortality | Adult | Female | Retrospective Studies | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Europe - epidemiology | Treatment Outcome | Heart Conduction System - drug effects | Anti-Arrhythmia Agents - therapeutic use | Propensity Score | Cardiomyopathy, Hypertrophic - mortality | Atrial Fibrillation - epidemiology | Heart Conduction System - physiopathology | Cardiomyopathy, Hypertrophic - physiopathology | Aged | Cardiomyopathy, Hypertrophic - epidemiology | Longitudinal Studies | Atrial Fibrillation - prevention & control | Electrocardiography, Ambulatory | Complications and side effects | Cardiomyopathy | Atrial fibrillation | Patient outcomes | Research | Heart diseases | Risk factors | Hypertrophy | Heart failure | Hypertension | Cardiac arrhythmia | Stroke | Disease | Mortality | Clinical outcomes | Studies | Variables | Ethics | Survival analysis | Hospitals | Data collection | Diabetes | Thromboembolism | Cardiology | Index Medicus | Abridged Index Medicus
Journal Article